Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Litigation Details for ALLERGAN, INC. v. APOTEX INC. (M.D.N.C. 2012)

Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ALLERGAN, INC. v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .

Details for ALLERGAN, INC. v. APOTEX INC. (M.D.N.C. 2012)

Date Filed Document No. Description Snippet Link To Document
2015-01-13 114 alia, asserted claim 14 of U.S. Patent No. 7,351,404 B2 (“the ‘404 patent”) invalid as obvious; …infringement of the 054 patent in Civil Action No. 13-CV-16; The 988, 161, and 054 patents are declared and …988, 161, and 054 patents against Apotex or contesting the invalidity of those patents; This case is not…Plaintiff Allergan, Inc.’s U.S. Patent Nos. 8,038,988 B2 (“the ‘988 patent”), 8,101,161 Case 1:…15 Page 1 of 3 B2 (“the ‘161 patent”), and 8,263,054 B2 (“the ‘054 patent”), which are listed in the External link to document
2012-03-20 6 Amended Complaint FDA U.S. Patent Nos. 7,351,404 (“the ’404 patent), 7,388,029 (“the ’029 patent”) and 6,403,649 (“the ’…infringement of United States Patent No. 8,038,988 (“the ’988 patent”) under the Patent Laws of the United States… THE PATENT-IN-SUIT 37. On October 18, 2011, the ’988 patent, entitled “Method…Allergan subsequently listed the ’988 patent with the FDA after that patent issued. 40. Latisse…reviews pharmaceutical patents and seeks opportunities to challenge those patents. 42. On External link to document
2013-02-24 77 Declaration Copy of U.S. Patent No. 7,351,404, # 3 Exhibit C Copy of U.S. Patent No. 8,038,988 (988 patent), # 4 Exhibit….S. Patent No. 8,101,161 (161 patent), # 5 Exhibit E Copy of U.S. Patent No. 8,263,054 (954 patent), #… 988 Patent Prosecution History, including 1/22/10 Amendment, # 7 Exhibit G Excerpt of 161 Patent Prosecution… 054 Patent Prosecution History, including 5/17/12 Amendment, # 9 Exhibit I Excerpt of 988 Patent Prosecution…Terminal Disclaimer, # 10 Exhibit J Excerpt of 161 Patent Prosecution History, including 1/22/10 Terminal External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.